In March 2020, EMOTRA AB (“Emotra”) carried out a rights issue of Units (where each unit comprises two (2) shares and (2) subscription warrants). .... 200403 - Emotra- PM - Final day for tradel in BTU
INVESTORS
EMOTRA AB: Emotra has appointed Mangold Fondkommission as the liquidity guarantor for shares in the Company, listed on the Spotlight Stock Market
The purpose of a liquidity guarantor is to ensure market liquidity for a share and reduce the difference between buy and sell prices. This duty will commence on March 27, 2020. 200326 - Emotra- PM - Liquidity guarantor
Emotra has signed a collaboration agreement for clinical studies with Linköping University
Lately, Emotra has been focusing on the indication area depression relapse, with the goal of starting a clinical study in 2020. 200325 - Emotra - PM - Emotra signs collaboration agreement for clinical studies
EMOTRA AB: Results of the rights issue
On March 18, 2020, the subscription period for shares in EMOTRA AB’s (“EMOTRA” or “the Company”) rights issue, encompassing a maximum of 8,796,586 Units..... 200323 - Emotra- PM - Results of the rights issue
Emotra is close to sealing collaboration agreement for clinical studies
We are working to expand our portfolio and are close to achieving further milestones in our new indication area for EDOR® test – depression relapse. 200309 - Emotra - PM - Emotra close to sealing collaboration agreement for clinical studies
Emotra will be participating in the Mangold Insight investor day
This March, Emotra AB (“Emotra”) will be presenting the Company as well as our present situation, goals and strategy to create a new market for EDOR test in the psychiatric care sector. 200303- Emotra - News letter - Emotra participates in the Mangold Insight...
EMOTRA AB: Resolution on a new rights issue of shares for continued documentation and future market introduction of EDOR® – Corrected
(Correction: This correction regards a mistake in the terms for subscription warrants; the correct terms are stated below under “Summary of terms for subscription warrants”) 200224 - Emotra- PM - Issue resolution FINAL_Correction_clean
Correction regarding the publication date for our Q1-2020 report
Correction: Emotra’s Year-end report for 2019 stated the wrong publication date for our interim report for the first quarter 2020. The correct date is May 29, 2020. 200226 - Emotra - PM - Correction regarding our Q1 2020 report
Emotra AB (publ) Year-end report January 1 – December 31, 2019
The Board and CEO of Emotra AB herewith present the year-end report for the financial year 2019. 200221- Year-end report 2019
EMOTRA AB: Resolution on a new rights issue of shares for continued documentation and future market introduction of EDOR®
Today, February 24, 2020, EMOTRA AB (“Emotra” or the “Company”) announced that the Board has decided to carry out a rights issue comprising a maximum of 8,796,586 units. 200224 - Emotra- PM - Issue resolution